Aktis Oncology, Inc.

Aktis Oncology, Inc. - Current Ratioverified

AKTS

Price:

$24.09

Market Cap:

$1.29B

Aktis Oncology, Inc. is a clinical-stage biotechnology firm dedicated to advancing targeted radiopharmaceutical therapies for cancer treatment. Their core innovation lies in a proprietary miniprotein radioconjugate platform, which enables the discovery and development of potent radiopharmaceutical therapies designed to precisely deliver tumor-killing radioisotopes. Among their pipeline candidates is Nectin-4, a miniprotein radioconjugate specifically engineered to treat locally advanced or metastatic urothelial cancer. Key programs also include AKY-1189, a radioconjugate engineered to target Nectin-4 expressing tumors across various indications such as metastatic urothelial cancer, breast ca...[Read more]

Industry

Biotechnology

IPO Date

2026-01-09

Stock Exchange

NASDAQ

Ticker

AKTS

The Current Ratio as of June 2026 (TTM) for Aktis Oncology, Inc. (AKTS) is 19.49

According to Aktis Oncology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 19.49. This represents a change of 49.58% compared to the average of 13.03 of the last 4 quarters.

Aktis Oncology, Inc. (AKTS) Historical Current Ratio (quarterly & annually)

How has AKTS Current Ratio performed in the past?

The mean historical Current Ratio of Aktis Oncology, Inc. over the last ten years is 16.13. The current 19.49 Current Ratio has changed 11.98% with respect to the historical average. Over the past ten years (40 quarters), AKTS's Current Ratio was at its highest in in the March 2026 quarter at 19.49. The Current Ratio was at its lowest in in the December 2025 quarter at 7.37.

Quarterly (TTM)
Annual

Average

16.13

Median

16.03

Minimum

7.37

Maximum

25.11

Aktis Oncology, Inc. (AKTS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aktis Oncology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Current Ratio = 25.11

Minimum Annual Increase = -53.87%

Minimum Annual Current Ratio = 7.37

Quarterly (TTM)
Annual
YearCurrent RatioChange
20257.37-53.87%
202415.98-0.51%
202316.07-36.03%

Aktis Oncology, Inc. (AKTS) Average Current Ratio

How has AKTS Current Ratio performed in the past?

The current Current Ratio of Aktis Oncology, Inc. (AKTS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

13.14

5-year avg

16.13

10-year avg

16.13

Aktis Oncology, Inc. (AKTS) Current Ratio vs. Peers

How is AKTS’s Current Ratio compared to its peers?

Aktis Oncology, Inc.’s Current Ratio is

CompanyCurrent RatioMarket cap

Build a custom stock screener for Aktis Oncology, Inc. (AKTS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aktis Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aktis Oncology, Inc. (AKTS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aktis Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Aktis Oncology, Inc.'s Current Ratio?

How is the Current Ratio calculated for Aktis Oncology, Inc. (AKTS)?

What is the highest Current Ratio for Aktis Oncology, Inc. (AKTS)?

What is the 3-year average Current Ratio for Aktis Oncology, Inc. (AKTS)?

What is the 5-year average Current Ratio for Aktis Oncology, Inc. (AKTS)?

How does the current Current Ratio for Aktis Oncology, Inc. (AKTS) compare to its historical average?